Join us in welcoming Sally Allain, the Head of Johnson & Johnson Innovation – JLABS @ Washington, DC, and Interim Head, JLABS North East. With experience supporting biotech startups and external partnering for Johnson & Johnson Innovation, Allain will share her insights on the different features and value available at a healthcare & life sciences incubator. Additionally, Allain will address:
- What an early-stage biotech should consider when applying for an incubator?
- What can a company can expect during its time at an incubator?
- How can a company maximize the value of an incubator?
- Opportunities with J&J Innovation – JLABS
Allain will also share insights into the trends that Johnson and Johnson Innovation is seeing for biotech and early-stage companies in 2023.